Development of novel ruthenium(ii)–arene complexes displaying potent anticancer effects in glioblastoma cells

Two bioactive Ru(ii)-p-cymene complexes are designed, structurally analysed, and investigated for their therapeutic potential in vitro against human glioblastoma (GB) cells.